Intriguing Peri-Strut Low-Intensity Area Detected by Optical Coherence Tomography After Coronary Stent Deployment
スポンサーリンク
概要
- 論文の詳細を見る
- 2010-05-25
著者
-
TERAMOTO Tomohiko
Department of Cardiovascular Medicine, Stanford University
-
IKENO Fumiaki
Department of Cardiovascular Medicine, Stanford University
-
OTAKE Hiromasa
Department of Cardiovascular Medicine, Stanford University
-
LYONS Jennifer
Department of Experimental Cardiology
-
VAN BEUSEKOM
Department of Experimental Cardiology
-
FEARON William
Department of Cardiovascular Medicine, Stanford University
-
YEUNG Alan
Department of Cardiovascular Medicine, Stanford University
-
Ikeno Fumiaki
Department Of Cardiovascular Medicine Stanford University School Of Medicine
-
Yeung Alan
Department Of Cardiovascular Medicine Stanford University
-
Ikeno Fumiaki
Department Of Cardiovascular Medicine Stanford University
-
Fearon William
Department Of Cardiovascular Medicine Stanford University
-
Teramoto Tomohiko
Department Of Cardiovascular Medicine Stanford University
-
Teramoto Tomohiko
Department Of Cardiology Hachioji Medical Center Tokyo Medical University
-
Otake Hiromasa
Department Of Cardiovascular Medicine Stanford University
-
Teramoto Tomohiko
Department of Cardiology , Hachioji Medical Center Tokyo Medical University
-
Ikeno Fumiaki
Department of Cardiology, Tokyo Women's Medical University
関連論文
- Intriguing Peri-Strut Low-Intensity Area Detected by Optical Coherence Tomography After Coronary Stent Deployment
- PJ-821 Differences in Angiographic Characterization of In-Stent Restenosis After Sirolimus Eluting Stent Implantation From Original De Novo Coronary Stenosis(Coronary revascularization, PCI(26)(IHD),Poster Session(Japanese),The 72nd Annual Scientific Meet
- PJ-378 Clinical outcomes of Sirolimus-eluting stent (SES) for AMI in this hospital : comparison with Bare metal stent (BMS)(Acute myocardial infarction, clinical(diagnosis/treatment)(10)(IHD),Poster Session(Japanese),The 72nd Annual Scientific Meeting of
- PJ-263 Predictors of Angiographical Restenosis and Major Adverse Cardiac Event after Sirolimus Eluting-Stent Implantation for Unprotected Left Main Coronary Artery Stenosis(Coronary revascularization, PCI(19)(IHD),Poster Session(Japanese),The 72nd Annual
- PJ-262 Long-term Outcomes Associated With Off-label Use of Sirolimuseluting Stents(Coronary revascularization, PCI(19)(IHD),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
- PJ-143 Definition of Incomplete Stent Apposition by Optical Coherence Tomography(Intravascular endoscopy/Intravascular ultrasound(05)(I),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
- PJ-057 Efficacy of Directional Coronary Atherectomy Prior to Sirolimus-Eluting Stent Implantation for Treatment of Unprotected Left Main Coronary Artery Bifurcation Stenosis(Coronary revascularization, PCI(16)(IHD),Poster Session(Japanese),The 72nd Annual
- OE-252 Optical Coherence Tomographic Analysis of Neointimal Coverrage of Sirolimus-eluting Stent in Patients with Acute Coronary Syndrome(Coronary revascularization, PCI(02)(IHD),Oral Presentation(English),The 72nd Annual Scientific Meeting of the Japanes
- PJ-821 Differences in Angiographic Characterization of In-Stent Restenosis After Sirolimus Eluting Stent Implantation From Original De Novo Coronary Stenosis(Coronary revascularization, PCI(26)(IHD),Poster Session(Japanese),The 72nd Annual Scientific Meet
- PJ-378 Clinical outcomes of Sirolimus-eluting stent (SES) for AMI in this hospital : comparison with Bare metal stent (BMS)(Acute myocardial infarction, clinical(diagnosis/treatment)(10)(IHD),Poster Session(Japanese),The 72nd Annual Scientific Meeting of
- PJ-263 Predictors of Angiographical Restenosis and Major Adverse Cardiac Event after Sirolimus Eluting-Stent Implantation for Unprotected Left Main Coronary Artery Stenosis(Coronary revascularization, PCI(19)(IHD),Poster Session(Japanese),The 72nd Annual
- PJ-057 Efficacy of Directional Coronary Atherectomy Prior to Sirolimus-Eluting Stent Implantation for Treatment of Unprotected Left Main Coronary Artery Bifurcation Stenosis(Coronary revascularization, PCI(16)(IHD),Poster Session(Japanese),The 72nd Annual
- OE-252 Optical Coherence Tomographic Analysis of Neointimal Coverrage of Sirolimus-eluting Stent in Patients with Acute Coronary Syndrome(Coronary revascularization, PCI(02)(IHD),Oral Presentation(English),The 72nd Annual Scientific Meeting of the Japanes
- Decrease of Fractional Flow Reserve Shortly After Percutaneous Coronary Intervention
- Pioglitazone Reduces the Necrotic-Core Component in Coronary Plaque in Association With Enhanced Plasma Adiponectin in Patients With Type 2 Diabetes Mellitus(Ischemic Heart Disease)
- 1 Catheter-based Transcoronary Myocardial Hypothermia Attenuates Reperfusion Injury in Pigs with Acute Myocardial Infarction(Discovery of Adjunctive Therapies for Acute Myocardial Infarction-From Bench to Bedside-, The 71st Annual Scientific Meeting of th
- OE-005 Additive Protection of Ischemic Heart by Combined Treatment with a Delta PKC Inhibitor and an Epsilon PKC Activator(Acute Myocardial Infarction, Basic 1 (IHD) : OE1)(Oral Presentation (English))
- Usefulness of the Thrombolysis Therapy for the Treatment of Acute Myocardial Infarction Using the Rescue^ Catheter
- Effect of Cytochrome P450 2C19 Polymorphism on Target Lesion Outcome After Drug-Eluting Stent Implantation in Japanese Patients Receiving Clopidogrel
- Qualitative and Quantitative Assessment of Stent Restenosis by Optical Coherence Tomography : – Comparison Between Drug-Eluting and Bare-Metal Stents –
- Global Cardiovascular Device Innovation: Japan-USA Synergies:– Harmonization by Doing (HBD) Program, a Consortium of Regulatory Agencies, Medical Device Industry, and Academic Institutions –
- Qualitative and Quantitative Assessment of Stent Restenosis by Optical Coherence Tomography : Comparison Between Drug-Eluting and Bare-Metal Stents
- Global Cardiovascular Device Innovation : Japan-USA Synergies : Harmonization by Doing (HBD) Program, a Consortium of Regulatory Agencies, Medical Device Industry, and Academic Institutions